News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
835,992 Results
Type
Article (76843)
Company Profile (713)
Press Release (758415)
Multimedia
Podcasts (170)
Webinars (28)
Section
Business (228579)
Career Advice (3789)
Deals (39324)
Drug Delivery (139)
Drug Development (89652)
Employer Resources (203)
FDA (18059)
Job Trends (17195)
News (389511)
Policy (39014)
Tag
Academia (3004)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (128)
Alliances (56339)
ALS (147)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (261)
Approvals (18094)
Artificial intelligence (476)
Autoimmune disease (97)
Automation (29)
Bankruptcy (403)
Best Places to Work (12632)
BIOSECURE Act (23)
Biosimilars (167)
Biotechnology (445)
Bladder cancer (138)
Brain cancer (53)
Breast cancer (517)
Cancer (4096)
Cardiovascular disease (356)
Career advice (3245)
Career pathing (38)
CAR-T (252)
CDC (57)
Cell therapy (690)
Cervical cancer (33)
Clinical research (74495)
Collaboration (1435)
Company closure (4)
Compensation (945)
Complete response letters (61)
COVID-19 (2961)
CRISPR (84)
C-suite (613)
Cystic fibrosis (140)
Data (4781)
Decentralized trials (2)
Denatured (61)
Depression (111)
Diabetes (459)
Diagnostics (7094)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (220)
Drug pricing (194)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (96670)
Editorial (55)
Employer branding (25)
Employer resources (172)
Events (132325)
Executive appointments (997)
FDA (20617)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1284)
Gene editing (177)
Generative AI (45)
Gene therapy (557)
GLP-1 (1029)
Government (5361)
Grass and pollen (8)
Guidances (372)
Healthcare (20923)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (253)
Immuno-oncology (22)
Indications (58)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (196)
Interviews (745)
IPO (17832)
IRA (59)
Job creations (4987)
Job search strategy (2632)
Kidney cancer (16)
Labor market (81)
Layoffs (639)
Leadership (37)
Legal (9964)
Liver cancer (92)
Longevity (12)
Lung cancer (590)
Lymphoma (271)
Machine learning (31)
Management (66)
Manufacturing (656)
MASH (145)
Medical device (14881)
Medtech (14907)
Mergers & acquisitions (22393)
Metabolic disorders (1175)
Multiple sclerosis (140)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2746)
NextGen: Class of 2025 (7643)
Non-profit (5096)
Now hiring (60)
Obesity (568)
Opinion (315)
Ovarian cancer (140)
Pain (171)
Pancreatic cancer (176)
Parkinson's disease (242)
Partnered (29)
Patents (427)
Patient recruitment (334)
Peanut (57)
People (65214)
Pharmaceutical (134)
Pharmacy benefit managers (29)
Phase I (22994)
Phase II (32449)
Phase III (24512)
Pipeline (2813)
Policy (299)
Postmarket research (3283)
Preclinical (10203)
Press Release (72)
Prostate cancer (203)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (696)
Real estate (7197)
Recruiting (79)
Regulatory (27405)
Reports (65)
Research institute (2690)
Resumes & cover letters (591)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (140)
Series A (213)
Series B (159)
Service/supplier (27)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (169)
Sponsored (41)
Startups (4223)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (107)
Vaccines (1056)
Venture capital (67)
Weight loss (402)
Women's health (58)
Worklife (21)
Date
Last 7 days (785)
Last 30 days (2708)
Last 365 days (32786)
2025 (27311)
2024 (37920)
2023 (42567)
2022 (53928)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39098)
2017 (36856)
2016 (37803)
2015 (43829)
2014 (38601)
2013 (34721)
2012 (36582)
2011 (36633)
2010 (36209)
Location
Africa (1210)
Alabama (80)
Alaska (7)
Arizona (286)
Arkansas (14)
Asia (49700)
Australia (8536)
California (9732)
Canada (2912)
China (938)
Colorado (411)
Connecticut (429)
Delaware (277)
Europe (112823)
Florida (1436)
Georgia (321)
Hawaii (3)
Idaho (66)
Illinois (810)
India (54)
Indiana (480)
Iowa (20)
Japan (335)
Kansas (125)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1305)
Massachusetts (7278)
Michigan (314)
Minnesota (576)
Mississippi (4)
Missouri (124)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2707)
New Mexico (32)
New York (2636)
North Carolina (1420)
North Dakota (10)
Northern California (4459)
Ohio (305)
Oklahoma (22)
Oregon (49)
Pennsylvania (2016)
Puerto Rico (20)
Rhode Island (46)
South America (1576)
South Carolina (51)
South Dakota (1)
Southern California (3713)
Tennessee (151)
Texas (1517)
United States (35772)
Utah (292)
Virginia (251)
Washington D.C. (84)
Washington State (830)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
835,992 Results for "shionogi and co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Accepts Shionogi’s Ensitrelvir NDA as the First Oral Therapy for the Prevention of COVID-19 Following Exposure
September 3, 2025
·
9 min read
Press Releases
Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.
October 24, 2025
·
3 min read
Press Releases
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
October 31, 2025
·
8 min read
Business
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. announced the companies have completed an exclusive worldwide license agreement for the rights to MZE001, an investigational oral glycogen synthase 1 inhibitor that aims to address Pompe disease by limiting disease-causing glycogen buildup.
May 10, 2024
·
6 min read
Press Releases
IDWeek 2025: Shionogi Presents Real-World and Surveillance Data Reinforcing Role of Cefiderocol Across Range of Patient Populations and Difficult-to-Treat Infections
October 20, 2025
·
17 min read
Press Releases
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
October 1, 2025
·
6 min read
Press Releases
BioVersys and Shionogi Enter Into Global Research Collaboration For Broad-Spectrum Non-Tuberculous Mycobacteria (NTM) Clinical Candidate
July 2, 2025
·
8 min read
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
Business
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results
Akili, Inc. including an amendment to its strategic distribution agreement with Shionogi & Co., Ltd. (“Shionogi”), a leading global pharmaceutical company.
April 30, 2024
·
9 min read
Press Releases
NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
September 10, 2025
·
8 min read
1 of 83,600
Next
